#USA #Vancouver #FDA Clearance #Total Flow #TFA Cannula

Breakthrough in Cardiac Surgery: Total Flow Medical's TFA Cannula

Total Flow Medical, a pioneering company in medical devices, has recently achieved a significant milestone in the field of cardiac surgery. The company announced the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Total Flow Medical Femoral Arterial (TFA) Cannula. This innovative device is specifically designed for use during cardiopulmonary bypass procedures, allowing clinicians to provide efficient extracorporeal circulation for patient safety and crisis management during cardiac surgeries.

The TFA Cannula is remarkable for its incorporation of a distal balloon feature, which enables the continuous flow of blood to the limb from which it is cannulated, significantly reducing the risks typically associated with femoral arterial cannulation. This ensures that blood continues to circulate in the cannulated limb, a crucial aspect often overlooked in surgical settings.

Hillary Pierce, CEO of Total Flow Medical, emphasized the importance of this FDA clearance, stating, "The TFA Cannula represents a pivotal milestone for Total Flow Medical. It is the product of a synergistic collaboration among perfusionists, engineers, and cardiac surgeons, all focused on enhancing the clinical approach to extracorporeal circulation. Receiving FDA clearance marks the commencement of our commercial trajectory to introduce this groundbreaking device across U.S. hospitals."

Traditionally, femoral arterial cannulation has been a standard practice to facilitate extracorporeal circulation during heart surgeries, but the preservation of blood flow to the limb has always posed challenges. The TFA Cannula addresses this clinical dilemma, allowing healthcare teams to integrate it seamlessly into existing surgical workflows without compromising patient safety.

In preparation for the TFA Cannula's market launch, Total Flow Medical is proactively engaging with cardiac surgical centers to ensure a smooth transition to clinical adoption. The company is dedicated to providing extensive support and education around the device's uses and benefits, aiming to enhance the quality of care provided to patients undergoing cardiac procedures.

About the TFA Cannula

The Total Flow Medical Femoral Arterial (TFA) Cannula is indicated for extracorporeal circulation during cardiopulmonary bypass procedures for durations of up to six hours. The device is engineered to be used in adult patients who present with a common femoral artery size of at least 7.5mm. Its unique design aims to facilitate proper insertion and placement, crucial for successful cardiac procedures.

The introduction of the TFA Cannula is expected to revolutionize practices in cardiac surgery, ensuring that patient care is at the forefront of surgical innovations. With a focus on addressing previously unmet clinical needs in extracorporeal circulation, Total Flow Medical is well-positioned to drive forward advancements in medical technology and improve surgical outcomes for patients.

To learn more about the TFA Cannula and Total Flow Medical’s innovative medical solutions, visit Total Flow Medical's website.